Back to VRTX
Assenagon Asset Management S.A. → VRTX
Assenagon Asset Management S.A. VRTX Position History
Vertex Pharmaceuticals Incorporated • Healthcare
Quarters held
6
Latest value
$637.5M
Q3 2026
Peak value
$637.5M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $299.1M |
| Q4 2025 | $377.6M |
| Q1 2026 | $239.9M |
| Q2 2026 | $377.3M |
| Q2 2026 | $377.3M |
| Q3 2026 | $637.5M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $637.5M | 1.22M | — | — |
| Q2 2026 | $377.3M | 759.6K | — | — |
| Q2 2026 | $377.3M | 759.6K | — | — |
| Q1 2026 | $239.9M | 537.2K | — | — |
| Q4 2025 | $377.6M | 832.9K | — | — |
| Q3 2025 | $299.1M | 763.7K | — | — |
Other funds holding VRTX
$10.8B
$10.1B
$9.8B
$8.5B
$5.9B
$5.9B
$5.7B
$5.5B